Healthcare -
Biotechnology - NASDAQ - US
$ 19.6
1.34 %
$ 3.27 B
Market Cap
14.41
P/E
Price Target
Average
40.31%
Revenue Forecast
Estimate
25.06%
EBIT
Estimate
--106.31%
Net Income
Estimate
99.21%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
ACADIA Pharmaceuticals Inc.
Wall Street analysts predict an average 1-year price target for ACAD of $27.5 , with forecasts ranging from
a
low of
$19 to a high of $39 .
ACAD Lowest Price Target
Wall Street Target
19 USD
-3.06%
ACAD Average Price Target
Wall Street Target
27.5 USD
40.31%
ACAD Highest Price Target
Wall Street Target
39 USD
98.98%
REVENUE FORECAST
Revenue Forecast Chart ACAD
EBIT FORECAST
EBIT Forecast Chart ACAD
NET INCOME FORECAST
Net Income Chart ACAD